Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01451853
Recruitment Status : Not yet recruiting
First Posted : October 14, 2011
Last Update Posted : September 25, 2017
Sponsor:
Collaborator:
VA Puget Sound Health Care System
Information provided by (Responsible Party):
Sound Pharmaceuticals, Incorporated

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : June 26, 2019
  Estimated Study Completion Date : September 23, 2019
Publications:
Lynch E, Kil J. Development of Ebselen, a Glutathione Peroxidase Mimic, for the Prevention and Treatment of Noise-Induced Hearing Loss. Semin Hear 2009; 30(1): 047-055